HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Distinct efficacy of pegylated-interferon α2a and α2b during treatment of essential thrombocythemia.

AuthorsNicolas Noel, Jean-Marie Michot, Caroline Besson, Cécile Goujard, Olivier Lambotte
JournalInternational journal of hematology (Int J Hematol) Vol. 97 Issue 3 Pg. 438-9 (Mar 2013) ISSN: 1865-3774 [Electronic] Japan
PMID23400413 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • JAK2 protein, human
  • Janus Kinase 2
  • peginterferon alfa-2b
  • peginterferon alfa-2a
Topics
  • Amino Acid Substitution
  • Antiviral Agents (administration & dosage)
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (administration & dosage)
  • Janus Kinase 2 (genetics, metabolism)
  • Middle Aged
  • Mutation, Missense
  • Polyethylene Glycols (administration & dosage)
  • Recombinant Proteins (administration & dosage)
  • Thrombocythemia, Essential (blood, drug therapy, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: